Related Experiment Video
Updated: Jun 21, 2026
07:59
A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
Edaxadiene: a new bioactive diterpene from Mycobacterium tuberculosis
Francis M Mann1, Meimei Xu, Xiaoming Chen
1Iowa State University, Department of Biochemistry, Biophysics, and Molecular Biology, Ames, Iowa 5001, USA.
Journal of the American Chemical Society
|July 9, 2009
Summary
Researchers characterized a novel enzyme from Mycobacterium tuberculosis that creates a unique diterpene called edaxadiene. This compound disrupts the host cell
Area of Science:
- Microbiology
- Biochemistry
- Natural Product Synthesis
Background:
- Mycobacterium tuberculosis is a significant global pathogen.
- Understanding its virulence factors is crucial for developing new treatments.
Purpose of the Study:
- To characterize an atypical class I diterpene cyclase from M. tuberculosis.
- To investigate its role in producing novel metabolites with potential anti-infective properties.
Main Methods:
- Enzyme characterization of a novel diterpene cyclase.
- Analysis of the cyclization reaction of halimadienyl diphosphate.
- Identification and structural elucidation of the novel diterpene product, edaxadiene.
Main Results:
- An atypical class I diterpene cyclase was identified and characterized.
- The enzyme catalyzes an unusual cyclization of halimadienyl diphosphate.
- A novel diterpene, edaxadiene, was synthesized and found to inhibit phagosomal maturation.
Conclusions:
- The characterized diterpene cyclase produces edaxadiene, a novel molecule.
- Edaxadiene's ability to inhibit phagosomal maturation suggests a new mechanism of M. tuberculosis pathogenesis.
- This discovery opens avenues for novel therapeutic strategies against tuberculosis.
